1.
肺癌患者化疗前后不同时期EORTC-C30各领域得分比较(Mean±SD)
Compare of the scores for EORTC QLQ-C30 in different periods of chemotherapy (Mean±SD)
| Baseline | After 2 cycles | After 4 cycles | F | P | |
| If the scores are normal distribution, they are expressed as Mean±SD, and use analysis of variance, SNK comparative method; if the scores are not normal distribution, they are expressed as median, and use Kruskal-Wallis rank sum test; *Compare with before chemotherapy and after 2 cycles, P < 0.05;△Compare with after 2 cycles and after 4 cycles, P < 0.05; ※Compare with before chemotherapy and after 4 cycles, P < 0.05. | |||||
| Physical | 79.964±11.145 | 74.390±10.320 | 67.809±14.812△※ | 5.477 | 0.005 |
| Role | 65.064±23.637 | 61.858±19.064 | 51.921±20.270△※ | 5.495 | 0.005 |
| Emotional | 63.603±25.890 | 62.173±20.717 | 49.648±18.230△※ | 6.420 | 0.002 |
| Cognitive | 64.721±28.890 | 67.931±21.592 | 67.623±18.201 | 0.299 | 0.742 |
| Social | 63.131±23.432 | 55.452±77.391* | 42.622±12.553△※ | 16.611 | 0.000 |
| Fatigue | 49.731±25.152 | 48.543±21.901 | 54.722±20.042 | 1.107 | 0.333 |
| Pain | 25.642±24.790 | 30.772±21.990 | 37.182±23.241※ | 3.184 | 0.044 |
| Nause and vomiting | 20.832±20.012 | 29.704±20.841* | 37.513±20.051△※ | 8.459 | 0.000 |
| Dyspnoea | 49.351±33.990 | 37.163±25.281 | 41.022±24.371 | 2.535 | 0.083 |
| Insomnia | 32.042±31.641 | 45.512±26.441* | 46.153±24.851※ | 4.270 | 0.160 |
| Appetite loss | 33.974±30.610 | 46.793±28.221* | 64.754±27.561△※ | 14.96 | 0.000 |
| Constipation | 28.204±20.141 | 31.413±30.551 | 43.594±32.701 | 2.972 | 0.054 |
| Diarrhea | 28.843±27.101 | 29.493±29.271 | 28.843±27.041 | 0.008 | 0.992 |
| Financial impact | 38.464±32.613 | 41.664±32.931 | 55.134±36.091△※ | 3.537 | 0.032 |
| Global quality of life | 58.637±22.761 | 53.194±15.598 | 45.810±14.351△※ | 6.693 | 0.002 |